Physician profile
Kd Wainwright
NPI 1326557646
$4,888.40
in general payments reported to CMS, 2019-2025
15 companies · $1,045 in 2025
The $1,045 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2023: $1,058 · 2024: $2,640 · 2025: $1,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,577 · Travel and Lodging: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,576.80 |
| Travel and Lodging | $1,165.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,729.74 | 2023-2025 | Spravato |
| Abbvie INC. | $965.27 | 2021-2025 | |
| Alkermes, INC. | $360.35 | 2023-2025 | Lybalvi, Aristada |
| Axsome Therapeutics, INC. | $288.50 | 2024-2025 | Auvelity, Sunosi |
| Neurocrine Biosciences, INC. | $285.47 | 2023-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $220.85 | 2024-2025 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $204.13 | 2023-2025 | Rexulti, Abilify Maintena |
| Takeda Pharmaceuticals U.S.A., INC. | $195.84 | 2023-2025 | Trintellix |
| Lundbeck LLC | $154.01 | 2023-2025 | Rexulti, Brintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $142.43 | 2023-2024 | Caplyta |
| Bausch Health US, LLC | $120.15 | 2023-2024 | Aplenzin |
| Teva Pharmaceuticals USA, INC. | $115.71 | 2023-2025 | Austedo Xr, Austedo Xr |
| Corium, LLC | $74.34 | 2025 | Azstarys |
| Owp Pharmaceuticals, INC. | $17.83 | 2023 | Subvenite, Lamotrigine |
| Collegium Pharmaceutical, INC. | $13.78 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kd Wainwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.